{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:06:38Z","timestamp":1784700398024,"version":"3.55.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Apolipoprotein L1 (\n                      <jats:italic>APOL1<\/jats:italic>\n                      ) renal risk variants (RRVs) contribute to the increased risk of kidney disease among Black Americans, but use of genetic testing may be limited by patient concerns regarding clinical implications and effects on family.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Black adults were prospectively enrolled for\n                      <jats:italic>APOL1<\/jats:italic>\n                      genotyping, surveys, and clinical record review beginning in January 2019 at a Midwestern U.S. medical center (NCT05656261). Patient-reported concerns about kidney conditions and potential worry related to having an\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotype were analyzed at baseline and 3-months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 200 participants enrolled with completed 3-month follow-up as of January 2025, 17.5% (35\/200) carried an\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotype (2 RRVs). At baseline, concern about kidney conditions was common: 39% reported being extremely concerned, 34% very concerned, 12% somewhat concerned, 10% a little concerned, and 6% not concerned at all. Higher baseline concern was observed among women and those with a family history of both kidney disease and hypertension. At 3 months, concern levels were unchanged in 45% of participants, decreased in 36%, and increased in 19%.\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotypes were more common in those with an increase, compared to a decrease, in kidney concern at follow-up (29% vs 11%; P\u00a0=\u00a00.02). Worry related to having an\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotype declined over time, from 14% at baseline to 8% at 3 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this prospective cohort, patient-reported concerns about kidney conditions were common and generally stable, with higher levels observed in certain subgroups. Although\n                      <jats:italic>APOL1<\/jats:italic>\n                      high-risk genotypes were more common among participants whose kidney concerns increased than among those whose concerns decreased, overall patient-reported worry about genetic risk declined. These findings may help inform patient education and counseling surrounding\n                      <jats:italic>APOL1<\/jats:italic>\n                      testing.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneph.2026.1815147","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:53:14Z","timestamp":1784699594000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the test: patient-reported concerns and worries regarding kidney conditions and APOL1 genetic testing among Black patients"],"prefix":"10.3389","volume":"6","author":[{"given":"Rengin","family":"Elsurer Afsar","sequence":"first","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Clair","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Saint Louis University","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza Anwar","family":"Memon","sequence":"additional","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Edwards","sequence":"additional","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana N.","family":"Miyata","sequence":"additional","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Afsar","sequence":"additional","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schnitzler","sequence":"additional","affiliation":[{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Xiao","sequence":"additional","affiliation":[{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Carriker","sequence":"additional","affiliation":[{"name":"Mid-America Transplant","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadee","family":"Abu Al Rub","sequence":"additional","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-yuan","family":"Hsu","sequence":"additional","affiliation":[{"name":"University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony N.","family":"Muiru","sequence":"additional","affiliation":[{"name":"University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Freedman","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine","place":["Winston-Salem, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie D.","family":"Philipneri","sequence":"additional","affiliation":[{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Caliskan","sequence":"additional","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[{"name":"SSM Health Saint Louis University Hospital","place":["St. Louis, MO, United States"]},{"name":"Saint Louis University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Study Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.kint.2025.05.017","article-title":"APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"108","author":"Ojo","year":"2025","journal-title":"Kidney Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-024-02194-1","article-title":"Depression and anxiety in people with kidney disease: understanding symptom variability, patient experience and preferences for mental health support","volume":"38","author":"Chilcot","year":"2025","journal-title":"J Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf067","article-title":"Patient and caregiver perspectives on mental health in children and adolescents with chronic kidney disease","volume":"18","author":"Torrisi","year":"2025","journal-title":"Clin Kidney J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000000000401","article-title":"The role of genetic testing in adult CKD","volume":"35","author":"Knoers","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32013","article-title":"The emotional effects of genetic diseases: implications for clinical genetics","author":"McAllister","year":"2007","journal-title":"Am J Med Genet A"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/1526924819854485","article-title":"A focus group study on African American living donors' treatment preferences, sociocultural factors, and health beliefs about apolipoprotein L1 genetic testing","volume":"29","author":"Gordon","year":"2019","journal-title":"Prog Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"35834","DOI":"10.1038\/s41598-025-19881-z","article-title":"Towards better illness perception in advanced chronic kidney disease: clinical, psychological and cognitive factors to address","volume":"15","author":"Tamarit","year":"2025","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.1048","article-title":"Effects of testing and disclosing ancestry-specific genetic risk for kidney failure on patients and health care professionals: a randomized clinical trial","volume":"5","author":"Nadkarni","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1002\/jgc4.1653","article-title":"Attitudes and beliefs regarding race-targeted genetic testing of Black people: a systematic review","volume":"32","author":"Iltis","year":"2023","journal-title":"J Genet Couns"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100549","article-title":"APOL1 genetic testing in patients with recent African ancestry and hypertension: a pilot study of attitudes and perceptions","volume":"4","author":"Lentine","year":"2022","journal-title":"Kidney Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2026.1771125","article-title":"Apolipoprotein L1 genetic testing, family history of hypertension, and kidney disease in a Midwestern U.S. cohort","volume":"6","author":"Lentine","year":"2026","journal-title":"Front Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/109019818401100101","article-title":"The Health Belief Model: a decade later","volume":"11","author":"Janz","year":"1984","journal-title":"Health Educ Q"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2015.12.020","article-title":"Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry","volume":"47","author":"Horowitz","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"B16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1681\/asn.0000000607","article-title":"Practical considerations for sharing race-based genetic research findings","volume":"36","author":"Iltis","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016004266.x","article-title":"Somatic symptom reporting in women and men","volume":"16","author":"Barsky","year":"2001","journal-title":"J Gen Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.09.023","article-title":"Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes","volume":"102","author":"Halbreich","year":"2007","journal-title":"J Affect Disord"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1370\/afm.242","article-title":"Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research","volume":"2","author":"Walter","year":"2004","journal-title":"Ann Fam Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000000000249","article-title":"The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease","volume":"34","author":"Dahl","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000356244","article-title":"Perceptions regarding genetic testing in populations at risk for nephropathy","volume":"38","author":"Freedman","year":"2013","journal-title":"Am J Nephrol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0323814","article-title":"Trajectories of illness perceptions in patients with kidney disease receiving dialysis: relationship with psychological and physical symptoms","volume":"20","author":"Keskindag","year":"2025","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/nejmc1800748","article-title":"Worldwide frequencies of APOL1 renal risk variants","volume":"379","author":"Nadkarni","year":"2018","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.35914","article-title":"Attitudes of African Americans toward return of results from exome and whole genome sequencing","author":"Yu","year":"2013","journal-title":"Am J Med Genet A"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1815147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:53:16Z","timestamp":1784699596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1815147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":24,"alternative-id":["10.3389\/fneph.2026.1815147"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2026.1815147","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1815147"}}